Search research articles
Contact Us
Filters
Showing results (21-30 of 190) with videos related to
Page
of 19
Sort By:
Journal of Hepatology
|
October 18, 2020
Reply to: "A spotlight on natural killer cells in primary biliary cholangitis"
Marco Carbone, Vincenzo Ronca, Pietro Invernizzi
JHEP Reports : Innovation in Hepatology
|
December 17, 2024
Challenges in the diagnosis and management of AIH-PBC syndrome
Alessio Gerussi, Pietro Invernizzi, Marco Carbone
Annals of Translational Medicine
|
February 3, 2017
The "gut microbiota" hypothesis in primary sclerosing cholangitis
Valerio Pontecorvi, Marco Carbone, Pietro Invernizzi
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
September 12, 2012
Prevention of hepatitis C recurrence after liver transplantation: An update
Marco Carbone, Ilaria Lenci, Leonardo Baiocchi
Minerva Gastroenterology
|
March 1, 2023
Autoimmune liver diseases
Miki Scaravaglio, Marco Carbone, Pietro Invernizzi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 28, 2022
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis
Jennifer Christine Halma, Laura Cristoferi, Marco Carbone
Journal of Pediatric Orthopedics. Part B
|
March 12, 2019
Treatment of early-onset scoliosis with growing rods in patients with neurofibromatosis-1
Marco Carbone, Francesca Vittoria, Alice Del Sal
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 14, 2025
Improving Primary Biliary Cholangitis Outcomes in the Evolving Landscape of Second-Line Therapies
Miki Scaravaglio, Vincenzo Ronca, Marco Carbone, et al.
Digestive Diseases (Basel, Switzerland)
|
December 8, 2015
Geoepidemiology, Genetic and Environmental Risk Factors for PBC
Haiyan Zhang, Marco Carbone, Ana Lleo, et al.
Hepatology (Baltimore, Md.)
|
October 31, 2009
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!"
Leonardo Baiocchi, Ilaria Lenci, Marco Carbone, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 190) with videos related to
Sort By:
Page
of 19
Journal of Hepatology
|
October 18, 2020
Reply to: "A spotlight on natural killer cells in primary biliary cholangitis"
Marco Carbone, Vincenzo Ronca, Pietro Invernizzi
JHEP Reports : Innovation in Hepatology
|
December 17, 2024
Challenges in the diagnosis and management of AIH-PBC syndrome
Alessio Gerussi, Pietro Invernizzi, Marco Carbone
Annals of Translational Medicine
|
February 3, 2017
The "gut microbiota" hypothesis in primary sclerosing cholangitis
Valerio Pontecorvi, Marco Carbone, Pietro Invernizzi
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
September 12, 2012
Prevention of hepatitis C recurrence after liver transplantation: An update
Marco Carbone, Ilaria Lenci, Leonardo Baiocchi
Minerva Gastroenterology
|
March 1, 2023
Autoimmune liver diseases
Miki Scaravaglio, Marco Carbone, Pietro Invernizzi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 28, 2022
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis
Jennifer Christine Halma, Laura Cristoferi, Marco Carbone
Journal of Pediatric Orthopedics. Part B
|
March 12, 2019
Treatment of early-onset scoliosis with growing rods in patients with neurofibromatosis-1
Marco Carbone, Francesca Vittoria, Alice Del Sal
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 14, 2025
Improving Primary Biliary Cholangitis Outcomes in the Evolving Landscape of Second-Line Therapies
Miki Scaravaglio, Vincenzo Ronca, Marco Carbone, et al.
Digestive Diseases (Basel, Switzerland)
|
December 8, 2015
Geoepidemiology, Genetic and Environmental Risk Factors for PBC
Haiyan Zhang, Marco Carbone, Ana Lleo, et al.
Hepatology (Baltimore, Md.)
|
October 31, 2009
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!"
Leonardo Baiocchi, Ilaria Lenci, Marco Carbone, et al.
Page
of 19